Amla juice, derived from the Indian gooseberry (Phyllanthus emblica), has been traditionally used for its potential health benefits, including its role in liver health. This review synthesizes evidence from various studies evaluating the impact of daily consumption of Amla juice over a 40-day period on liver function parameters. The studies reviewed include diverse populations, such as healthy adults, patients with fatty liver, individuals with metabolic syndrome, and the elderly with non-alcoholic fatty liver disease (NAFLD). Key liver function parameters, such as alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transferase (GGT), and serum bilirubin, were consistently monitored. The findings demonstrate that Amla juice consumption is associated with significant reductions in ALT and AST levels, improvement in serum bilirubin, and beneficial effects on lipid profiles, indicating its potential for liver function enhancement and as a complementary therapy for liver-related conditions. However, further research is needed to fully elucidate the mechanisms involved and to determine optimal dosages for various populations.